Can large national health plans make an impact in reducing prescribing of high-risk medications to people with Alzheimer's ...

Most discontinued anti-tau antibodies (red) targeted tau’s N-terminus. Of the antibodies currently in trials (green), bepranemab and E2814 presented results at CTAD, while JJ-63733657/posdinemab and ...

Anavex announced new data from their phase 2b/3 Alzheimer's trial, which was presented at the CTAD 2024 conference. Read why ...

Why should I get a memory test? As we age, our brains undergo both anatomical and chemical changes. Shrinkage begins in our 30s and 40s, with the prefrontal cortex, cerebellum and ...

Dementia is the umbrella term for all kinds of conditions associated with memory loss of which Alzheimer’s disease is the ...

The science around dementia and Alzheimer's disease has grown over the past two decades. Thousands of area residents have ...

Cassava Sciences, Inc. (NASDAQ:SAVA) Q3 2024 Earnings Call Transcript November 7, 2024 Cassava Sciences, Inc. beats earnings ...

President and CEO: Jake Allen - Goldman Sachs: Sung Ji Nam - Scotiabank: Kyle Mikson - Canaccord Genuity: Puneet Souda - ...

It primarily measures language and memory abilities and consists of 11 parts, taking approximately 30 minutes to administer. How is your memory? The Alzheimer ... of questions to assess various ...

There’s a set of childhood memories that UC Santa Barbara film and media studies professor Cristina Venegas returns to once ...

At 5:30 p.m., while ... We answered some common questions. Scientists have made another major stride toward the long-sought goal of diagnosing Alzheimer’s with a simple blood test.